SLC12A2 and Huntington disease: In mouse models of HD, NKCC1 and KCC2 are altered in the hippocampus and striatum, which results in weakened inhibition and paradoxical excitatory actions of GABA (Dargaei et al., 2018; Hsu et al., 2019).